一株同时携带质粒介导KPC-2、DHA-1基因对碳青霉烯类药物耐药的产气肠杆菌

doi:10.3969/j.issn.1673-8640.2014.04.017

检验医学 ›› 2014, Vol. 29 ›› Issue (4): 375-379.DOI: 10.3969/j.issn.1673-8640.2014.04.017

一株同时携带质粒介导KPC-2、DHA-1基因对碳青霉烯类药物耐药的产气肠杆菌

蒯守刚¹，王卫萍²，裴豪¹，范明¹，刘君²，周希科²，尚忠波²，邵海枫¹

1.无锡市第五人民医院，江苏无锡 214005；2.南京军区南京总医院，江苏南京210002

收稿日期:2013-06-07 出版日期:2014-04-30 发布日期:2014-06-06
通讯作者: 邵海枫，联系电话:0510-80219555-3203。
作者简介:蒯守刚，男，1975年生，硕士，主管技师，主要从事临床微生物检验工作。

A clinical isolate of carbapenem-resistant Enterobacter aerogen with plasmid-mediated KPC-2 and DHA-1 genes

KUAI Shougang¹, WANG Weiping², PEI Hao¹, FAN Ming¹, LIU Jun², ZHOU Xike², SHANG Zhongbo², SHAO Haifeng¹.

1.Wuxi Fifth People′s Hospital, Jiangsu Wuxi 214005, China;
2. Nanjing General Hospital of Nanjing Military Command, Jiangsu Nanjing 210002, China

Received:2013-06-07 Online:2014-04-30 Published:2014-06-06

摘要/Abstract

摘要：

目的　研究一株临床分离的碳青霉烯类药物耐药产气肠杆菌的耐药机制和耐药基因传播机制。方法　采用琼脂稀释法检测菌株对抗菌药物的最低抑菌浓度（MIC），采用质粒接合试验、质粒提取、DNA 分子杂交、等电聚焦电泳（IEF）、聚合酶链反应（PCR）、DNA测序和外膜蛋白分析研究菌株的耐药基因及其传递机制。结果　IEF显示临床分离的产气肠杆菌株含有3条β-内酰胺酶条带，等电点（pI）分别为5.4、6.7和7.8。PCR扩增及测序结果表明它们分别为TEM-1（pI 5.4）、KPC-2（pI 6.7）、DHA-1（pI 7.8） β-内酰胺酶。接合菌含有2条β-内酰胺酶条带，pI为6.7和7.8。接合试验、质粒提取和分子杂交试验结果显示KPC-2和DHA-1基因定位于同一个约56 kb大小的质粒上。与临床野生产气肠杆菌株相比，外膜蛋白电泳分析显示耐药分离株缺失41 000外膜蛋白。结论　产气肠杆菌分离株对碳青霉烯类抗菌药物耐药可能由A类2f组KPC-2酶介导，DHA-1酶合并外膜蛋白缺失也可能与碳青霉烯类药物耐药机制形成有关。

关键词: 产气肠杆菌, 碳青霉烯类, 质粒, β-内酰胺酶, 肠杆菌科

Abstract:

Objective　To investigate the resistance and transmission mechanisms of a clinical isolate of carbapenem-resistant Enterobacter aerogen. Methods　The minimal inhibition concentrations（MIC） of antimicrobial agents were determined by agar dilution method， and plasmid conjugation experiment， plasmid extraction and DNA molecular hybridization， isoelectric focusing electrophoresis（IEF）， polymerase chain reaction（PCR）， DNA sequencing and outer-membrane protein analysis were used for analyzing the resistant gene and transmission mechanism. Results IEF showed that there were 3 bands of beta-lactamases with isoelectric point（pI） of 5.4， 6.7 and 7.8 in the clinical isolate of carbapenem-resistant Enterobacter aerogen. These 3 bands of beta-lactamases were confirmed to be TEM-1（pI 5.4）， KPC-2（pI 6.7） and DHA-1（pI 7.8） by PCR amplification and DNA sequencing， and 2 of them（pIs of 6.7 and 7.8） were found that they can be transferred by plasmid conjugantion experiment. KPC-2 and DHA-1 genes were located on an about 56 kb plasmid by plasmid conjugation experiment， plasmid extraction and DNA molecular hybridization. Outer-membrane protein electrophoresis analysis revealed that a 41 000 outer-membrane protein was absent in the clinical isolate of carbapenem-resistant Enterobacter aerogen comparing with clinical wild-type Enterobacter aerogen. Conclusions The clinical isolate of Enterobacter aerogen resistant to carbapenem produces a plasmid-mediaed carbapemase KPC-2 which belongs to Group 2f， Class A beta-lactamase. DHA-1 enzyme with outer-membrane protein absence may be related with the resistant mechanism of carbapenem-resistance in the isolate of Enterobacter aerogen.

Key words: Enterobacter aerogen, Carbapenem, Plasmid, Beta-lactamase, Enterobacteriaceae

中图分类号:

R378.2

蒯守刚，王卫萍，裴豪，范明，刘君，周希科，尚忠波，邵海枫. 一株同时携带质粒介导KPC-2、DHA-1基因对碳青霉烯类药物耐药的产气肠杆菌[J]. 检验医学, 2014, 29(4): 375-379.

KUAI Shougang，WANG Weiping，PEI Hao，FAN Ming，LIU Jun，ZHOU Xike，SHANG Zhongbo，SHAO Haifeng. A clinical isolate of carbapenem-resistant Enterobacter aerogen with plasmid-mediated KPC-2 and DHA-1 genes[J]. , 2014, 29(4): 375-379.

参考文献

[1] Queenan AM,Bush K. Carbapenemases: the versatile beta-lactamases[J]. Clin Microbiol Rev, 2007, 20(3): 440-458.
[2] Miriagou V,Cornaglia G, Edelstein M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues[J]. Clin Microbiol Infect, 2010, 16(2):112-122.
[3] Nordmann P,Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria[J]. Lancet Infect Dis, 2009, 9(4):228-236.
[4] Hanson ND , Moland ES, Hossain A, et al. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases[J]. J Antimicrob Chemother, 2002, 49(6):1011-1014.
[5] Héritier C, Poirel L, Aubert D, et al. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii[J] . Antimicrob Agents Chemother, 2003,47(1): 268-273.
[6] 蒯守刚,邵海枫,王卫萍,等.耐碳青酶烯类肠杆菌科细菌的耐药机制研究[J]. 中华医院感染学杂志, 2010, 20(22):3441-3444.
[7] Smith Moland E, Hanson ND, Herrera VL, et al. Plasmid-mediated carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates[J]. Antimicrob Agents Chemother, 2003, 51(3): 711-714.
[8] Nüesch-Inderbinen MT, Hchler H, Kayser FH. Detection of genes coding extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method and comparison with the E test[J]. Eur J Clin Microbiol Infect Dis, 1996, 15(5): 398-402.
[9] Rasheed JK, Jay C, Metchock B, et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia[J]. Antimicrob Agents Chemother, 1997, 41(3): 647-653.
[10] Edelstein M, Pimkin M,Palagin I,et al. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals[J]. Antimicrob Agents Chemother, 2003, 47(12): 3724-3732.
[11] Grimont F, Grimont PAD. Prokaryotes: a handbook on the biology of bacteria[M]. 3rd ed. New York: Springer, 2006: 219-244.
[12] 蒯守刚,裴豪,陈燕燕,等.亚胺培南耐药大肠埃希菌基因型检测[J].检验医学, 2011,26(10): 653-657.
[13] 蒯守刚,邵海枫,王卫萍,等.大肠埃希菌对碳青霉烯类药物的耐药机制研究[J].中华微生物学和免疫学杂志,2010,30(9):829-833.
[14] Chenia HY, Pillay B, Pillay D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens[J]. J Antimicrob Chemother,2006,58(6):1274-1278.

[1]	王佳玮, 朱威南, 陈颖盈, 季萍, 王颖. 血培养分离碳青霉烯类耐药肺炎克雷伯菌临床分布和耐药基因分析[J]. 检验医学, 2023, 38(4): 362-367.
[2]	杨思敏, 轩乾坤, 羽晓瑜, 温冬华, 李广波. 国产某品牌大肠埃希菌和肺炎克雷伯菌及3种碳青霉烯耐药基因试剂性能验证[J]. 检验医学, 2023, 38(1): 56-59.
[3]	朱丰村, 曾云祥, 金晓立, 曾添, 黄天鹏, 林枝, 周林双. 204株碳青霉烯类耐药肠杆菌目细菌耐药性分析[J]. 检验医学, 2023, 38(1): 60-65.
[4]	徐琪, 潘芬, 孙燕, 石迎迎, 于方圆, 张泓. 肠道定植CRE筛查技术方法学评价[J]. 检验医学, 2022, 37(8): 761-765.
[5]	孙英, 李轶, 闫文娟, 荆楠, 马冰. 河南地区少见CRE耐药性分析及碳青霉烯酶初筛实验的临床应用[J]. 检验医学, 2022, 37(2): 146-149.
[6]	王芳, 邓燕燕, 林见敏, 王金金, 龚倩, 黄声雷. 改良碳青霉烯灭活试验和碳青霉烯酶抑制剂增强试验鉴定肠杆菌目细菌产碳青霉烯酶型别的临床价值[J]. 检验医学, 2022, 37(12): 1183-1186.
[7]	包海林, 花鸿燕, 孙恒亮, 刘华, 吉顺年, 秦陈浩, 杜鸿. 改良Carba Np试验和mCIM/eCIM快速鉴定产碳青霉烯酶肠杆菌科细菌表型的临床应用[J]. 检验医学, 2022, 37(10): 963-968.
[8]	姚锂凤, 郑巧平, 杨蒙, 罗清琼, 陈旭, 陈福祥. 胶体金免疫层析法快速检测CRE碳青霉烯酶效果评价[J]. 检验医学, 2022, 37(1): 68-71.
[9]	尹娟, 王莹超, 眭阳, 江春, 时蕴琦, 朱超望. mCIM与eCIM在产碳青霉烯酶肠杆菌科细菌表型筛查中的价值[J]. 检验医学, 2021, 36(2): 177-180.
[10]	杨红梅, 陶建敏, 魏甜, 王蒋君, 毛嘉宏, 王海英. 2015—2019年上海某中西医结合医院住院患者碳青霉烯类耐药肠杆菌科细菌耐药性分析[J]. 检验医学, 2021, 36(1): 87-91.
[11]	陆书华, 李晓哲, 刘凌云, 金呈强, 戈宁宁, 董海新. 山东某院耐碳青霉烯类肠杆菌科细菌临床感染特征及耐药基因分析[J]. 检验医学, 2020, 35(8): 757-762.
[12]	王军杰, 姚宗会, 马冰, 李轶, 闫文娟, 王山梅, 马琼, 袁有华. 碳青霉烯类耐药肺炎克雷伯菌致血流感染危险因素及预后分析[J]. 检验医学, 2020, 35(3): 195-199.
[13]	王粟, 赵虎. 碳青霉烯类耐药肠杆菌科细菌临床检测与治疗方案的发展及应用[J]. 检验医学, 2020, 35(10): 967-970.
[14]	周宏伟, 胡燕燕, 张嵘. 碳青霉烯类耐药肠杆菌科细菌的检测方法[J]. 检验医学, 2020, 35(10): 971-973.
[15]	邹成韵, 杨红梅, 王海英. 碳青霉烯类耐药肠杆菌科细菌去定植策略研究现状[J]. 检验医学, 2020, 35(10): 974-978.

一株同时携带质粒介导KPC-2、DHA-1基因对碳青霉烯类药物耐药的产气肠杆菌

A clinical isolate of carbapenem-resistant Enterobacter aerogen with plasmid-mediated KPC-2 and DHA-1 genes

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics